Psoriasis

Nuvothera Launches Next-Gen, Super-Micronized Turmeric Supplement

 
Art Clapp, Founder & CEO of Nuvothera, a Fort Worth, TX-based biotech company formed by seasoned dermatology pharmaceutical executives with the mission of developing novel OTC products for chronic, difficult-to-treat skin diseases such as psoriasis joins eHealth Radio and the Dermatology and Pharmaceutical Channels.
 
Listen to interview with host Eric Michaels & guest Art Clapp discuss the following:
Why did you start the company Nuvothera?
Why did you focus your product development on Turmeric?
How does turmeric have so many health benefits?
What is different about your turmeric?
What are other wellness suggestions beyond supplements?

Art Clapp is Founder & CEO of Nuvothera, a Fort Worth, TX-based biotech company formed by seasoned dermatology pharmaceutical executives with the mission of developing novel OTC products for chronic, difficult-to-treat skin diseases such as psoriasis. Nuvothera’s products incorporate natural botanical ingredients and use the latest in scientific knowledge and evidence-based research. Currently, the company has two products in its portfolio, both available via the company website and on Amazon: Prosoria™ Daily Psoriasis Treatment System and Nuvothera™ Super-Micronized™ Turmeric Curcumin. Both dermatologists (MDs) and scientists (PhDs) were involved in developing these products, which are dermatology and clinically tested and proven. In 2018, Art was named Entrepeneur of the Year by the Fort Worth Business Press and Nuvothera won the Tech FW (Fort Worth) Impact Award for a product that has the potential to impact our world.
Art has three decades of experience in pharmaceuticals managing US and international pharma markets in licensing, acquisitions, technology assessment, product development, commercialization, Rx and OTC product marketing, strategic planning, portfolio and product life-cycle management, and delivery systems.
Prior to founding Nuvothera, Art spent almost two decades at Galderma in Pharmaceutical Marketing and Business development roles Fort Worth, TX and in Paris, France.
He also spent thirteen years in Sales and Product managemen at Purdue Pharma in Norwalk, CT.
 
 
Website: nuvothera.com

Q&A with Dr. Lawrence Green: New Psoriasis Treatment

 
 
Dr. Lawrence Green, a Board Certified Dermatologist based in Washington, DC joins eHealth Radio and the Dermatology & Health News Channels. In honor of the recent World Psoriasis Day, Dr. Green discusses psoriasis, it’s causes, and treatment options including SILIQ, a new FDA-approved treatment for the condition.
Listen to interview with host Eric Michaels & guest Dr. Lawrence Green discuss the following:
What is Psoriasis?
What Treatment Options Are Available?
Can You Tell Us More About SILIQ?
Who is the Ideal Candidate for SILIQ?
What Makes SILIQ Different?
 
Dr. Lawrence Green completed his undergraduate training at the University of Michigan, and earned his medical degree from New York Medical College in 1989. He completed his dermatology and dermasurgery residency at the University of California, Irvine, concentrating on advanced cosmetic skin surgery. In addition to this formal training, Dr. Green also completed a research fellowship focusing on new treatments for aging skin and therapies for psoriasis. Dr. Lawrence Green has been voted a top dermatologist by Washingtonian Magazine in 2005, 2008, 2010, 2011,2014, and 2015. He has been selected as a Washington DC area "Super Doctor," has been listed in the national edition of Castle Connolly Top Doctor's directory, and is also listed in the Global Directory of WHO's WHO as a top doctor in Washington DC.  Dr. Green is frequently interviewed by national television networks, radio, and large circulation newspapers and magazines.
As a past board member for the National Psoriasis Foundation, and member of the Acne and Rosacea Society, Dr. Green is called upon for his insight on difficult to treat medical conditions such as acne and psoriasis.He is regularly selected to speak to other dermatologists concerning emerging therapies for fat reduction, wrinkle fillers, and aging/sun damaged skin.
 
 
Websites: Siliq.com | Psoriasis.org

Dermatologist Developed Total Relief Scalp Therapy

Dr. Gary L. Marder, board certified dermatologist and Founder of Total Relief Scalp Therapy products joins eHealth Radio and the Dermatology & Skin Care Channels.
 
Listen to interview with host Eric Michaels and guest Dr. Gary L. Marder discuss the following:
How did you go from being a dermatologist to creating your own product line? 
What makes your product so unique compared to the other scalp products available?
What exactly is dandruff and seborrheic dermatitis and what causes it?
What other products do you have in store for us?
 
For over 30 years Dr. Gary L. Marder has been a board-certified dermatologist. He is the Medical Director of Marder Dermatology, with two offices in Florida, and the Founder of Dr. Marder's Total Relief Shampoo & Conditioner line. After decades of seeing patients who suffered from dry, itchy scalp and incessant dandruff, accomplished dermatologist Dr. Marder set forth to develop a revolutionary product that would help his patients and fellow dandruff sufferers around the world.
Recognizing the scalp as a sensitive part of the skin that needs proper nourishment, Dr. Marder's Total Relief Shampoo & Conditioner line is formulated without sulfates or common irritants found in most hair products. The shampoo and conditioner are formulated with natural extracts and antioxidants such as resveratrol, citric acid, coriander fruit oil and essential vitamins. What makes Dr. Marder's Total Relief™ Shampoo different from all other products is the addition of maximum strength cortisone.
 
Website: www.drmarderskincare.com
Social Media Links: Facebook: https://www.facebook.com/DrMarderSkincare Twitter: https://twitter.com/drmarderskin

New Treatment option for Plaque Psoriasis

Dr. Mark Jackson of Forefront Dermatology, a Board Certified Dermatologist and Psoriasis Expert joins eHealth Radio and the Dermatology & Health News Channels to tell us about Sernivo, a new FDA-approved treatment for Psoriasis.
Listen to interview with host Eric Michaels and guest Dr. Mark Jackson discuss the following:What is Psoriasis?What causes Psoriasis? Is there a cure?How can it be treated?Can you tell us a bit more about Sernivo?Psoriasis can impact a patient’s quality of life, what makes it so frustrating?
Duration: 9:37
Dr. Jackson is a Clinical Professor of Medicine (Dermatology) at the University of Louisville. Dr. Jackson is active in the dermatology residency program and spends time teaching dermatology residents and medical students. He is also involved in clinical investigational research, as well as in clinical practice.
Dr. Jackson has authored many chapters and articles in peer reviewed publications and has lectured throughout the country on topics involving acne, lupus, psoriasis, eczema, systemic therapies for dermatologic diseases and advanced dermatologic disorders. He sees patients primarily at the Louisville office, but also staffs the dermatology clinic at the University of Louisville.
Dr. Jackson also serves as an investigator and consultant for pharmaceutical companies in research and drug development.

Website: www.sernivo.com